The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6
Open accessAbstract
The developmental switch from human fetal (γ) to adult (β) hemoglobin represents a clinically important example of developmental gene regulation. The transcription factor BCL11A is a central mediator of γ-globin silencing and hemoglobin switching. Here we determine chromatin occupancy of BCL11A at the human β-globin locus and other genomic regions in vivo by high-resolution chromatin immunoprecipitation (ChIP)–chip analysis. BCL11A binds the upstream locus control region (LCR), ɛ-globin, and the intergenic regions between γ-globin and δ-globin genes. A chromosome conformation capture (3C) assay shows that BCL11A reconfigures the β-globin cluster by modulating chromosomal loop formation. We also show that BCL11A and the HMG-box-containing transcription factor SOX6 interact physically and functionally during erythroid maturation. BCL11A and SOX6 co-occupy the human β-globin cluster along with GATA1, and cooperate in silencing γ-globin transcription in adult human erythroid progenitors. These findings collectively demonstrate that transcriptional silencing of γ-globin genes by BCL11A involves long-range interactions and cooperation with SOX6. Our findings provide insight into the mechanism of BCL11A action and new clues for the developmental gene regulatory programs that function at the β-globin locus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Subsequent studies demonstrated that BCL11A, a zinc- fi nger transcription factor, is a bona fi de repressor of HbF expression (4 -7).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Further molecular studies revealed that BCL11A interacts with several erythroid regulators including GATA1, FOG1, and SOX6, and with the nucleosome remodeling and deacetylase complex (NuRD) (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In control cells, ChIP analysis revealed that BCL11A occupies several discrete regions within the human β -globin cluster, including the DNase I hypersensitive site 3 (HS3) within the locus control region (LCR), the e -globin promoter, and the γδ -intergenic region, consistent with previous analyses (4, 6).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,503
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Position-independent, high-level expression of the human β-globin gene in transgenic mice
Grosveld, F. G., van Assendelft, G. B., Greaves, D. R., & Kollias, G. A. (1987) · Cell · doi:10.1016/0092-8674(87)90584-8 · Cited by 1,908
The UCSC Genome Browser Database
Karolchik, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg129 · Cited by 1,890
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Simonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., de Wit, E., van Steensel, B., & de Laat, W. (2006) · Nature Genetics · doi:10.1038/ng1896 · Cited by 1,386
Looping and Interaction between Hypersensitive Sites in the Active β-globin Locus
Tolhuis, B., Palstra, R.-J., Splinter, E., Grosveld, F., & de Laat, W. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00781-5 · Cited by 1,344
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Self-citationFrom head to toes: the multiple facets of Sox proteins
Wegner, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1409 · Cited by 890
Cited by
Sorted by citations
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Xu, K., Wu, Z. J., Groner, A. C., He, H. H., Cai, C., Lis, R. T., Wu, X., Stack, E. C., Loda, M. F., Liu, T., et al. (2012) · Science · doi:10.1126/science.1227604 · Cited by 901
Defining functional DNA elements in the human genome
Kellis, M., Wold, B. J., Snyder, M. P., Bernstein, B., Kundaje, A. B., Marinov, G. K., Ward, L. D., Birney, E., Crawford, G. E., Dekker, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318948111 · Cited by 724
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Bauer, D. E., Kamran, S. C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M. C., Smith, E. C., Pinello, L., et al. (2013) · Science · doi:10.1126/science.1242088 · Cited by 653
Self-citationGenetics of Human Cardiovascular Disease
Kathiresan, S., & Srivastava, D. (2012) · Cell · doi:10.1016/j.cell.2012.03.001 · Cited by 513
Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
Self-citationReactivation of developmentally silenced globin genes by forced chromatin looping
Deng, W., Rupon, J. W., Krivega, I., Breda, L., Motta, I., Jahn, K. S., Reik, A., Gregory, P. D., Rivella, S., Dean, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.050 · Cited by 443
Primitive and definitive erythropoiesis in mammals
Palis, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00003 · Cited by 442
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Liu, X. S., & Brown, M. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 401
Self-citationTranscription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Masuda, T., Wang, X., Maeda, M., Canver, M. C., Sher, F., Funnell, A. P. W., Fisher, C., Suciu, M., Martyn, G. E., Norton, L. J., et al. (2016) · Science · doi:10.1126/science.aad3312 · Cited by 373
Self-citationKLF1 regulates BCL11A expression and γ- to β-globin gene switching
Zhou, D., Liu, K., Sun, C.-W., Pawlik, K. M., & Townes, T. M. (2010) · Nature Genetics · doi:10.1038/ng.637 · Cited by 367
The switch from fetal to adult hemoglobin.
Sankaran, V. G., & Orkin, S. H. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011643 · Cited by 333
Self-citationCorrection of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326
Self-citationXie, H., Xu, J., Hsu, J. H.-R., Nguyen, M., Fujiwara, Y., Peng, C., & Orkin, S. H. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.001 · Cited by 334
Self-citationMartyn, G. E., Wienert, B., Yang, L., Shah, M., Norton, L. J., Burdach, J., Kurita, R., Nakamura, Y., Pearson, R. C. M., Funnell, A. P. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0085-0 · Cited by 300
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver Cancer
Sun, X., Wang, S. C., Wei, Y., Luo, X., Jia, Y., Li, L., Gopal, P., Zhu, M., Nassour, I., Chuang, J.-C., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.007 · Cited by 260
Mimura, I., Nangaku, M., Kanki, Y., Tsutsumi, S., Inoue, T., Kohro, T., Yamamoto, S., Fujita, T., Shimamura, T., Suehiro, J.-I., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06643-11 · Cited by 251
Transcription factor networks in erythroid cell and megakaryocyte development
Doré, L. C., & Crispino, J. D. (2011) · Blood · doi:10.1182/blood-2011-04-285981 · Cited by 251
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303976110 · Cited by 233
Self-citationBcl11a is essential for lymphoid development and negatively regulates p53
Yu, Y., Wang, J., Khaled, W. T., Burke, S., Li, P., Chen, X., Yang, W., Jenkins, N. A., Copeland, N. G., Zhang, S., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121846 · Cited by 223
CD4 Helper and CD8 Cytotoxic T Cell Differentiation
Taniuchi, I. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053411 · Cited by 249
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Wilber, A. C., Nienhuis, A. W., & Persons, D. A. (2011) · Blood · doi:10.1182/blood-2010-11-316893 · Cited by 226
Comparison of DNA methylation profiles in human fetal and adult red blood cell progenitors
Lessard, S., Beaudoin, M., Benkirane, K., & Lettre, G. (2015) · Genome Medicine · doi:10.1186/s13073-014-0122-2 · Cited by 218
Molecular basis of β thalassemia and potential therapeutic targets
Thein, S. L. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.06.001 · Cited by 219
Lu, Q., Hu, Y., Sun, J., Cheng, Y., Cheung, K., & Zhao, H. (2015) · Scientific Reports · doi:10.1038/srep10576 · Cited by 197
Xu, J., Shao, Z., Glass, K., Bauer, D. E., Pinello, L., Handel, B. V., Hou, S., Stamatoyannopoulos, J. A., Mikkola, H. K. A., Yuan, G., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.09.003 · Cited by 207
Self-citationThe nucleosome remodeling and deacetylase complex in development and disease
Basta, J., & Rauchman, M. (2015) · Translational Research · doi:10.1016/j.trsl.2014.05.003 · Cited by 191
A Functional Element Necessary for Fetal Hemoglobin Silencing
Sankaran, V. G., Xu, J., Byron, R., Greisman, H. A., Fisher, C. A., Weatherall, D. J., Sabath, D. E., Groudine, M. T., Orkin, S. H., Premawardhena, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103070 · Cited by 184
Self-citationPredicting enhancer‐promoter interaction from genomic sequence with deep neural networks
Singh, S. K., Yang, Y., Póczos, B., & Ma, J. (2019) · Quantitative Biology · doi:10.1007/s40484-019-0154-0 · Cited by 176
The GATA factor revolution in hematology
Katsumura, K. R., Bresnick, E. H., & the GATA Factor Mechanisms Group (2017) · Blood · doi:10.1182/blood-2016-09-687871 · Cited by 184
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177
Self-citationLineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
Brendel, C., Guda, S., Renella, R., Bauer, D. E., Canver, M. C., Kim, Y.-J., Heeney, M. M., Klatt, D., Fogel, J., Milsom, M. D., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87885 · Cited by 167
Self-citationGiardine, B. M., Borg, J., Higgs, D. R., Peterson, K. R., Philipsen, S., Maglott, D. R., Singleton, B. K., Anstee, D. J., Başak, A. N., Clark, B. E., et al. (2011) · Nature Genetics · doi:10.1038/ng.785 · Cited by 161
Chang, K.-H., Smith, S. E., Sullivan, T., Chen, K., Zhou, Q., West, J. A., Liu, M., Liu, Y., Vieira, B. F., Sun, C., et al. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.009 · Cited by 155
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
Grevet, J. D., Lan, X., Hamagami, N., Edwards, C. R., Sankaranarayanan, L., Ji, X., Bhardwaj, S. K., Face, C. J., Posocco, D. F., Abdulmalik, O. Y., et al. (2018) · Science · doi:10.1126/science.aao0932 · Cited by 151
Xu, J., Shao, Z., Li, D., Xie, H., Kim, W., Huang, J., Taylor, J. E., Pinello, L., Glass, K., Jaffe, J. D., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.009 · Cited by 157
Self-citationMolecular Basis and Genetic Modifiers of Thalassemia
Mettananda, S., & Higgs, D. R. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.003 · Cited by 130
McGrath, K. E., Frame, J. M., Fromm, G. J., Koniski, A. D., Kingsley, P. D., Little, J. A., Bulger, M., & Palis, J. (2011) · Blood · doi:10.1182/blood-2010-12-325357 · Cited by 144
Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
Self-citationHuang, P., Keller, C. A., Giardine, B., Grevet, J. D., Davies, J. O. J., Hughes, J. R., Kurita, R., Nakamura, Y., Hardison, R. C., & Blobel, G. A. (2017) · Genes & Development · doi:10.1101/gad.303461.117 · Cited by 127
Dendritic cell fate is determined by BCL11A
Ippolito, G. C., Dekker, J. D., Wang, Y., Lee, B., Shaffer, A. L., Lin, J. X., Wall, J. K., Lee, B.-S., Staudt, L. M., Liu, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319228111 · Cited by 133
Wienert, B., Funnell, A. P. W., Norton, L. J., Pearson, R. C. M., Wilkinson‐White, L. E., Lester, K. L., Vadolas, J., Porteus, M. H., Matthews, J. M., Quinlan, K. G. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms8085 · Cited by 125
Gene Therapy for β-Hemoglobinopathies
Cavazzana, M., Antoniani, C., & Miccio, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.024 · Cited by 132
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction
Guda, S., Brendel, C., Renella, R., Du, P., Bauer, D. E., Canver, M. C., Grenier, J. K., Grimson, A., Kamran, S. C., Thornton, J. E., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.113 · Cited by 124
Self-citationBcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Luc, S., Huang, J., McEldoon, J. L., Somuncular, E., Li, D., Rhodes, C., Mamoor, S., Hou, S., Xu, J., & Orkin, S. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.064 · Cited by 126
Self-citationCyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and numberPreprint
Sankaran, V. G., Ludwig, L. S., Sicińska, E., Xu, J., Bauer, D. E., Eng, J. C., Patterson, H. C., Metcalf, R. A., Natkunam, Y., Orkin, S. H., et al. (2012) · Genes & Development · doi:10.1101/gad.197020.112 · Cited by 126
Self-citationMicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A
Lulli, V., Romania, P., Morsilli, O., Cianciulli, P., Gabbianelli, M., Testa, U., Giuliani, A., & Marziali, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060436 · Cited by 128
Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Cui, S., Kolodziej, K. E., Obara, N., Amaral-Psarris, A., Demmers, J., Shi, L., Engel, J. D., Grosveld, F. G., Strouboulis, J., & Tanabe, O. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05310-11 · Cited by 112
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation
Basak, A., Munschauer, M., Lareau, C. A., Montbleau, K. E., Ulirsch, J. C., Hartigan, C. R., Schenone, M., Lian, J., Wang, Y., Huang, Y., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0568-7 · Cited by 105
Self-citationRational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
Sher, F., Hossain, M. A., Seruggia, D., Schoonenberg, V. A. C., Yao, Q., Cifani, P., Dassama, L. M. K., Cole, M. A., Ren, C., Vinjamur, D. S., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0453-4 · Cited by 113
Self-citationFetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104
Update on fetal hemoglobin gene regulation in hemoglobinopathies
Bauer, D. E., & Orkin, S. H. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283420fd0 · Cited by 111
Self-citationDulmovits, B. M., Appiah‐Kubi, A., Papoin, J., Hale, J., He, M., Al‐Abed, Y., Didier, S., Gould, M., Husain-Krautter, S., Singh, S. A., et al. (2015) · Blood · doi:10.1182/blood-2015-09-667923 · Cited by 102
Chapin, J. C., & Giardina, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00040-8 · Cited by 101
Wilber, A. C., Hargrove, P. W., Kim, Y., Riberdy, J. M., Sankaran, V. G., Papanikolaou, E., Georgomanoli, M., Anagnou, N. P., Orkin, S. H., Nienhuis, A. W., et al. (2010) · Blood · doi:10.1182/blood-2010-08-300723 · Cited by 98
Self-citationRyba, T., Battaglia, D., Chang, B. H., Shirley, J. W., Buckley, Q., Pope, B. D., Devidas, M., Druker, B. J., & Gilbert, D. M. (2012) · Genome Research · doi:10.1101/gr.138511.112 · Cited by 99
Targeted Therapeutic Strategies for Fetal Hemoglobin Induction
Sankaran, V. G. (2011) · Hematology · doi:10.1182/asheducation-2011.1.459 · Cited by 102
Self-citationEpigenetic regulation of fetal globin gene expression in adult erythroid cells
Ginder, G. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.002 · Cited by 97
Pule, G. D., Mowla, S., Novitzky, N., Wiysonge, C. S., & Wonkam, A. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2015.1078235 · Cited by 103
KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome
Magor, G. W., Tallack, M. R., Gillinder, K. R., Bell, C. C., McCallum, N., Williams, B., & Perkins, A. C. (2015) · Blood · doi:10.1182/blood-2014-08-590968 · Cited by 92
Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells
Amaya, M., Desai, M., Gnanapragasam, M. N., Wang, S. Z., Zu Zhu, S., Williams, D. C., & Ginder, G. D. (2013) · Blood · doi:10.1182/blood-2012-11-466227 · Cited by 102
Sox6, jack of all trades: A versatile regulatory protein in vertebrate development
Hagiwara, N. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22639 · Cited by 88
Amplitude modulation of androgen signaling by c-MYCPreprint
Ni, M., Chen, Y., Fei, T., Li, D., Lim, E., Liu, X. S., & Brown, M. A. (2013) · Genes & Development · doi:10.1101/gad.209569.112 · Cited by 88
Self-citationTranscription factor competition at the γ-globin promoters controls hemoglobin switching
Liu, N., Xu, S., Yao, Q., Zhu, Q., Yan, K., Hsu, J. Y., Sakon, P., Pinello, L., Yuan, G., Bauer, D. E., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00798-y · Cited by 86
Self-citationThe LDB1 Complex Co-opts CTCF for Erythroid Lineage-Specific Long-Range Enhancer Interactions
Lee, J., Krivega, I. V., Dale, R., & Dean, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.072 · Cited by 83
A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis
Pimentel, H., Parra, M., Gee, S. L., Ghanem, D., An, X., Li, J., Mohandas, N., Pachter, L. S., & Conboy, J. G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1388 · Cited by 88
Genetic association studies in β-hemoglobinopathies
Thein, S. L. (2013) · Hematology · doi:10.1182/asheducation-2013.1.354 · Cited by 82
Analysis of chromatin-state plasticity identifies cell-type–specific regulators of H3K27me3 patterns
Pinello, L., Xu, J., Orkin, S. H., & Yuan, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322570111 · Cited by 76
Self-citationBCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
Yin, J., Xie, X., Ye, Y., Wang, L., & Che, F. (2019) · Bioscience Reports · doi:10.1042/bsr20190604 · Cited by 73
Andrades, Á., Peinado, P., Álvarez-Pérez, J. C., Sanjuán‐Hidalgo, J., García, D. J., Arenas, A. M., Matia‐González, A. M., & Medina, P. P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01736-8 · Cited by 81
Khosravi, M. A., Abbasalipour, M., Concordet, J., Berg, J. V., Zeinali, S., Arashkia, A., Azadmanesh, K., Buch, T., & Karimipoor, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.042 · Cited by 71
Trakarnsanga, K., Wilson, M. C., Lau, W. W. Y., Singleton, B. K., Parsons, S. F., Sakuntanaga, P., Kurita, R., Nakamura, Y., Anstee, D. J., & Frayne, J. (2014) · Haematologica · doi:10.3324/haematol.2014.110155 · Cited by 69
Tallack, M. R., & Perkins, A. C. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f59ba · Cited by 69
Cánovas, J., Berndt, F. A., Sepúlveda, H., Aguilar, R., Veloso, F. A., Montecino, M., Oliva, C., Maass, J. C., Sierralta, J., & Kukuljan, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0169-15.2015 · Cited by 63
Wu, X., Satpathy, A. T., Wumesh, K. C., Liu, P., Murphy, T. L., & MURPHY, K. M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064800 · Cited by 66
Sox6 enhances erythroid differentiation in human erythroid progenitors
Cantù, C., Ierardi, R., Alborelli, I., Fugazza, C., Cassinelli, L., Piconese, S., Bosè, F., Ottolenghi, S., Ferrari, G., & Ronchi, A. E. (2011) · Blood · doi:10.1182/blood-2010-04-282350 · Cited by 65
Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the β-Globinopathies
Suzuki, M., Yamamoto, M. P., & Engel, J. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00714-14 · Cited by 65
Regulation of the fetal hemoglobin silencing factor BCL11A
Basak, A., & Sankaran, V. G. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13024 · Cited by 68
Self-citationSentinels of chromatin: chromodomain helicase DNA-binding proteins in development and diseasePreprint
Alendar, A., & Berns, A. J. M. (2021) · Genes & Development · doi:10.1101/gad.348897.121 · Cited by 69
Kiefer, C. M., Lee, J., Hou, C., Dale, R. K., Lee, Y. T., Meier, E. R., Miller, J. L., & Dean, A. (2011) · Blood · doi:10.1182/blood-2011-06-363101 · Cited by 59
Transcription regulation by distal enhancers
Stadhouders, R., van den Heuvel, A., Kolovos, P., Jorna, R., Leslie, K. D., Grosveld, F. G., & Soler, É. (2012) · Transcription · doi:10.4161/trns.20720 · Cited by 60
Trakarnsanga, K., Wilson, M. C., Griffiths, R. E., Toye, A. M., Carpenter, L., Heesom, K. J., Parsons, S. F., Anstee, D. J., & Frayne, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100874 · Cited by 56
Pule, G. D., Mowla, S., Novitzky, N., & Wonkam, A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0092-7 · Cited by 59
Flores, C., Mojadidi, M., Phillips, J., Kuo, C. Y., Lai, S. Y., Lill, G. R., Cooper, A. R., Kaufman, M. L., Urbinati, F., Wang, X., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.52 · Cited by 53
Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease
Thein, S. L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_2 · Cited by 60
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif
Jehle, K., Cato, L., Neeb, A., Muhle-Goll, C., Jung, N., Smith, E. W., Buzon, V., Carbó, L. R., Estébanez-Perpiñá, E., Schmitz, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534859 · Cited by 53
“Thereafter ChIP was performed as previously described (34, 35) using following antibodies: anti-AR (N20, Santa Cruz), Bag-1L (36) and HA-tag (ab9110, Abcam).”
MethodThalassemias: from gene to therapy
Simone, G. D., Quattrocchi, A., Mancini, B., di Masi, A., Nervi, C., & Ascenzi, P. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101028 · Cited by 59
Reactivation of a developmentally silenced embryonic globin gene
King, A. J., Songdej, D., Downes, D. J., Beagrie, R. A., Liu, S., Buckley, M., Peng, H., Suciu, M., Oudelaar, A. M., Hanssen, L. L. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24402-3 · Cited by 57
Self-citationRivers, A. E., Vaitkus, K., Ruiz, M. A., Ibañez, V., Jagadeeswaran, R., Kouznetsova, T., DeSimone, J., & Lavelle, D. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.04.005 · Cited by 52
An, C.-I., Dong, Y., & Hagiwara, N. (2011) · BMC Developmental Biology · doi:10.1186/1471-213x-11-59 · Cited by 60
Reid, X. J., Low, J. K. K., & Mackay, J. P. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.06.002 · Cited by 57
Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice
Esteghamat, F., Gillemans, N., Bilić, I., van den Akker, E., Cantú, I., van Gent, T., Klingmüller, U., van Lom, K., Lindern, M. V., Grosveld, F. G., et al. (2013) · Blood · doi:10.1182/blood-2012-06-434530 · Cited by 52
Takase, S., Hiroyama, T., Shirai, F., Maemoto, Y., Nakata, A., Arata, M., Matsuoka, S., Sonoda, T., Niwa, H., Sato, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35404-0 · Cited by 50
Ma, Y., Wang, B., Jiang, F., Wang, D., Liu, H., Yan, Y., Dong, H., Wang, F., Gong, B., Zhu, Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00623-13 · Cited by 50
MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease
Li, Y., Zhu, X., Ward, C. M., Starlard‐Davenport, A., Takezaki, M., Berry, A., Ward, A., Wilder, C., Neunert, C. E., Kutlar, A., et al. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.11.002 · Cited by 51
CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
Demirci, S., Leonard, A. K., Essawi, K., & Tisdale, J. F. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.010 · Cited by 56
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
Shariati, L., Khanahmad, H., Salehi, M., Hejazi, Z., Rahimmanesh, I., Tabatabaiefar, M. A., & Modarressi, M. H. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2928 · Cited by 48
Strict in vivo specificity of the Bcl11a erythroid enhancer
Smith, E. C., Luc, S., Croney, D. M., Woodworth, M. B., Greig, L. C., Fujiwara, Y., Nguyen, M., Sher, F., Macklis, J. D., Bauer, D. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-736249 · Cited by 50
Self-citationZhu, X., Wang, Y., Pi, W., Liu, H., Wickrema, A., & Tuan, D. Y. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047175 · Cited by 47
Funnell, A. P. W., Mak, K. S., Twine, N. A., Pelka, G. J., Norton, L. J., Radziewic, T., Power, M., Wilkins, M. R., Bell-Anderson, K. S., Fraser, S. T., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00074-13 · Cited by 47
Metadata
- Authors
- Xu, J., Sankaran, V. G., Ni, M., Menne, T. F., Puram, R. V., Kim, W., & Orkin, S. H.
- Affiliations
- Boston Children's Hospital (US)
- Harvard University (US)
- Harvard–MIT Division of Health Sciences and Technology (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-04-15
- Volume
- 24
- Issue
- 8
- Pages
- 783-798
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC2854393
- OpenAlex
- W2134881764
- Semantic Scholar
- 097ee5589990708503598c372d66d87bf5262280
- Cited by
- 361
- References
- 71
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 19 · 2023: 15 · 2022: 23 · 2021: 21 · 2020: 20 · 2019: 17 · 2018: 21 · 2017: 31 · 2016: 30 · 2015: 25 · 2014: 26 · 2013: 23 · 2012: 22
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Kay Kendall Leukaemia Fund
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL032259, T32HL116324)
- National Cancer Institute (K12CA087723)
- National Institute of General Medical Sciences (T32GM007753)
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- BCL11A, SOX6, beta-globin locus, hemoglobin switching, long-range chromatin interactions, chromatin looping, locus control region, erythroid maturation, GATA-1, erythroid progenitor cells, developmental gene regulation, chromatin occupancy
- MeSH terms
- Adult, Animals, Carrier Proteins, Cell Line, Erythropoiesis, Histones, Humans, Nuclear Proteins, Protein Binding, Repressor Proteins, Gene Expression Regulation, Developmental, Gene Silencing, Protein Transport, Erythroid Cells, GATA1 Transcription Factor, Mice, gamma-Globins, SOXD Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review